Biotech | November 22, 2024
Merck Life Science India ink MoU with GeNext Genomics
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Donation drive in São Paulo aims to support 250 young women’s health and environmental responsibility
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Subscribe To Our Newsletter & Stay Updated
